+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PI3K Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PI3K Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
From
Apoptosis Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Apoptosis Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Anaplastic Lymphoma Kinase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Anaplastic Lymphoma Kinase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Brain Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Adrenocortical Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adrenocortical Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adenoid Cystic Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more